Symphony Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,739
Closed -$1.22M 108
2019
Q4
$1.22M Hold
10,739
0.27% 36
2019
Q3
$1.17M Hold
10,739
0.25% 42
2019
Q2
$1.05M Buy
10,739
+3,989
+59% +$364K 0.22% 56
2019
Q1
$615K Sell
6,750
-1,046
-13% -$93.6K 0.16% 95
2018
Q4
$709K Buy
+7,796
New +$729K 0.21% 48
2018
Q3
Sell
-8,729
Closed -$700K 259
2018
Q2
$700K Sell
8,729
-32,903
-79% -$2.75M 0.14% 140
2018
Q1
$3.34M Sell
41,632
-2,805
-6% -$231K 0.43% 58
2017
Q4
$3.59M Buy
+44,437
New +$3.56M 0.36% 61
2016
Q2
Sell
-22,182
Closed -$1.66M 387
2016
Q1
$1.66M Buy
22,182
+6,322
+40% +$476K 0.18% 134
2015
Q4
$1.22M Sell
15,860
-3
-0% -$226 0.13% 166
2015
Q3
$1.06M Buy
15,863
+1,076
+7% +$79.2K 0.13% 175
2015
Q2
$1.09M Buy
14,787
+1,879
+15% +$144K 0.14% 167
2015
Q1
$1.01M Buy
12,908
+1,247
+11% +$94.5K 0.12% 181
2014
Q4
$841K Buy
11,661
+780
+7% +$54.2K 0.1% 186
2014
Q3
$674K Sell
10,881
-388
-3% -$24.7K 0.07% 215
2014
Q2
$718K Buy
11,269
+6,044
+116% +$367K 0.07% 271
2014
Q1
$322K Sell
5,225
-5,301
-50% -$309K 0.03% 374
2013
Q4
$605K Sell
10,526
-4,866
-32% -$276K 0.04% 258
2013
Q3
$819K Sell
15,392
-28,593
-65% -$1.54M 0.08% 221
2013
Q2
$2.26M Buy
+43,985
New +$2.17M 0.22% 107

Other funds holding MDT

Symphony Asset Management's MDT Position: Q1 2020 in Review

Symphony Asset Management sold out of Medtronic (MDT) in Q1 2020, closing a stake of 10,739 shares — an estimated $1.22M sold.

Symphony Asset Management first reported a position in MDT in Q2 2013 and held it in 20 quarters. The position peaked at $3.59M in Q4 2017. 1,762 funds tracked by Wall St. Rank hold MDT as of Q1 2020.

  • Symphony Asset Management reported no remaining Medtronic position as of Q1 2020 after selling out during the quarter.
  • Symphony Asset Management sold 10,739 Medtronic shares in Q1 2020, an estimated $1.22M.
  • Symphony Asset Management first reported a position in Medtronic in Q2 2013 and held it in 20 quarters.
  • Symphony Asset Management's Medtronic position peaked at $3.59M in Q4 2017.
  • 1,762 funds tracked by Wall St. Rank held Medtronic as of Q1 2020.

Based on Symphony Asset Management's 13F filing for Q1 2020, filed 12 May 2020.